Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axsome Therapeutics (AXSM) Non-cash Items: 2022-2024

Historic Non-cash Items for Axsome Therapeutics (AXSM) over the last 3 years, with Dec 2024 value amounting to $146.6 million.

  • Axsome Therapeutics' Non-cash Items rose 10.99% to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year increase of 10.99%. This contributed to the annual value of $146.6 million for FY2024, which is 9.51% down from last year.
  • As of FY2024, Axsome Therapeutics' Non-cash Items stood at $146.6 million, which was down 9.51% from $162.0 million recorded in FY2023.
  • In the past 5 years, Axsome Therapeutics' Non-cash Items ranged from a high of $300.7 million in FY2022 and a low of $146.6 million during FY2024.
  • Its 3-year average for Non-cash Items is $203.1 million, with a median of $162.0 million in 2023.
  • Data for Axsome Therapeutics' Non-cash Items shows a maximum YoY crashed of 46.12% (in 2023) over the last 5 years.
  • Over the past 3 years, Axsome Therapeutics' Non-cash Items (Yearly) stood at $300.7 million in 2022, then crashed by 46.12% to $162.0 million in 2023, then dropped by 9.51% to $146.6 million in 2024.